Peilin Ma
About Peilin Ma
Peilin Ma is a scientist at Bristol Myers Squibb with extensive expertise in cell signaling, genetics, and epigenetics, particularly in acute myeloid leukemia.
Company
Peilin Ma is currently working at Bristol Myers Squibb as a Scientist. Bristol Myers Squibb is located in Summit, New Jersey, United States. The company is known for its focus on pharmaceutical products and innovative medical research, where Ma contributes to scientific projects and research initiatives.
Previous Positions
Peilin Ma has held multiple research and academic positions in prestigious institutions. From 2018 to 2019, Ma was a Senior Research Scientist at Memorial Sloan Kettering Cancer Center in New York City. Prior to that, Ma worked as a Research Assistant Professor at Indiana University School of Medicine from 2014 to 2018. At the University of Michigan, Ma served as a Research Investigator between 2012 and 2014. Earlier in Ma's career, from 2005 to 2012, Ma worked as a Postdoctoral Researcher at the Indiana University School of Medicine. Ma began an academic career as a Lecturer at Harbin Medical University from 1997 to 2005 in Harbin, China.
Education and Expertise
Peilin Ma achieved both Doctor of Philosophy (Ph.D.) in Microbiology and Immunology and Doctor of Medicine (M.D.) at Harbin Medical University. These degrees were obtained from 1999 to 2004 and 1992 to 1997, respectively. Ma has amassed extensive expertise in cell signaling, genetics, and epigenetics in normal and malignant hematopoiesis, particularly in acute myeloid leukemia. Ma's PhD training in Immunology has provided a strong foundation for a successful research career.
Research Focus
Peilin Ma has conducted extensive research in Hematology/Oncology, particularly at Indiana University and the University of Michigan. Ma is skilled in using in vivo animal models for biomedical research and has significant experience with flow cytometry for cellular analysis. These skills have been crucial in studying cell signaling, genetics, and epigenetics in normal and malignant hematopoiesis.